Bristol-Myers Squibb Canada Inc. v. Canada (Attorney General) et al., (2001) 266 N.R. 141 (FCA)
Linked as:
Extract
Bristol-Myers Squibb Canada Inc. v. Canada (Attorney General) et al., (2001) 266 N.R. 141 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- RJR-MacDonald Inc. et Imperial Tobacco Ltd. v. Canada (Procureur général), (1994) 164 N.R. 1 (SCC)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
- Crain (R.L.) Inc. v. Hendry, (1988) 67 Sask.R. 123 (QB)
- Zeneca Pharma Inc. v. Canada (Minister of National Health and Welfare) et al., (2000) 267 N.R. 6 (FCA)
- Apotex Inc. v. Canada (Minister of Health) et al., (1999) 165 F.T.R. 42 (TD)
